Saudi Research and Marketing Group

InvestmentPitch Media Video Discusses Nextech AR Solutions and its Update of Spin-Out of its Generative AI Powered Toggle3D Platform

Retrieved on: 
Friday, February 3, 2023
Metaverse, Marketing, Research, Saudi Research and Marketing Group, 3D, FSE, Canadian Securities Exchange, Iveco Bus, N29, OTCQX, AR, NTAR, CSE, E-commerce, Acceleration, News, Television, Security (finance), Nex Entertainment

The video is available for viewing on “ InvestmentPitch ” and on “ YouTube ”.

Key Points: 
  • The video is available for viewing on “ InvestmentPitch ” and on “ YouTube ”.
  • If these links are not enabled, please visit www.InvestmentPitch.com and enter “Nextech” in the search box.
  • Nextech plans to spin-out the Toggle3D platform and associated assets into a new Subco by way of a plan of arrangement.
  • Nextech AR Solutions leverages proprietary artificial intelligence (AI) to create 3D experiences for the metaverse.

Contextual Intelligence Leader Announces Free, Industry-Wide Contextual Certification Program

Retrieved on: 
Tuesday, January 24, 2023
Contextual, OMD, Research, Saudi Research and Marketing Group, Certification, Advertising, Metadata, Immediate Media Company, PII, History, Market, Accreditation, CTV, DACH, Intelligence, Chloramphenicol, Media Rating Council, Management

The certification is intended to educate media planners and buyers on contextual advertising and GumGum offerings, as the leader in contextual intelligence.

Key Points: 
  • The certification is intended to educate media planners and buyers on contextual advertising and GumGum offerings, as the leader in contextual intelligence.
  • The announcement follows the company’s pilot certification program launched in the Germany, Austria and Switzerland (DACH) regions last year.
  • GumGum’s contextual certification program is a free, flexible, self-paced training and assessment that will empower individuals to navigate the complex contextual advertising landscape.
  • The program is 30 minutes-long and covers the history of contextual advertising, contextual strategy, a look behind the lens on the technology that makes contextual intelligence possible and information on the Media Rating Council who manage measurement accreditation for the advertising industry.

EQS-News: Defence Therapeutics Inc.:  DEFENCE TO PRESENT AT THE 9TH ANNUAL IMMUNO-ONCOLOGY 360º SUMMIT IN NEW-YORK FEBRUARY 7-10, 2023

Retrieved on: 
Thursday, February 2, 2023
ARM, IO, Cancer, Therapy, Saudi Research and Marketing Group, Conference, Patient, Science, Cell, Medicine, Pharmaceutical industry, Defense, Research

Defence Therapeutics Inc.:  DEFENCE TO PRESENT AT THE 9TH ANNUAL IMMUNO-ONCOLOGY 360º SUMMIT IN NEW-YORK FEBRUARY 7-10, 2023

Key Points: 
  • Defence Therapeutics Inc.:  DEFENCE TO PRESENT AT THE 9TH ANNUAL IMMUNO-ONCOLOGY 360º SUMMIT IN NEW-YORK FEBRUARY 7-10, 2023
    The issuer is solely responsible for the content of this announcement.
  • DEFENCE TO PRESENT AT THE 9TH ANNUAL IMMUNO-ONCOLOGY 360º SUMMIT IN NEW-YORK FEBRUARY 7-10, 2023.
  • www.io360summit.com
    Defence’s CEO, Mr. Sébastien Plouffe and Dr. Moutih Rafei, VP-Research and Development are looking forward to meeting you at the booth #16 during the Conference.
  • In addition, Dr. Moutih Rafei will present live on Cell Therapy Day on Tuesday February 7th at 5:25 pm on Track A “Novel Engineered Cell Therapies and Concepts”.

InvestmentPitch Media Video Discusses Nextech AR Solutions and its Report of Preliminary 2022 Revenues, with 3D Modeling Revenue Surging 266%

Retrieved on: 
Monday, January 16, 2023
Metaverse, News, Saudi Research and Marketing Group, CSE, FSE, 3D, Research, Marketing, Growth, Patent, Iveco Bus, Software, OTCQX, N29, NTAR, E-commerce, Video game, 3D printing

The company reported preliminary total revenue of $10.3 million for fiscal 2022, with $7.2 million from the legacy eCommerce business.

Key Points: 
  • The company reported preliminary total revenue of $10.3 million for fiscal 2022, with $7.2 million from the legacy eCommerce business.
  • Technology services generated $3.1 million in revenue, with gross margins increasing from 28% in 2021 to 43% in 2022, an increase of 53%.
  • The company is actively using this breakthrough, part-based 3D model creation technology and has expanded its library to more than 100,000 3D model parts.
  • These parts are used to create a 3D model as most 3D models are composed of several individual parts.

InvestmentPitch Media Video Discusses Nextech AR Solutions’ New Patent for AI Technology 3D Model Creation and 2nd Pending Spinout, Positioning Company for Exceptional 2023

Retrieved on: 
Wednesday, January 11, 2023
Metaverse, News, Saudi Research and Marketing Group, CSE, FSE, 3D, Research, Marketing, Patent, Iveco Bus, OTCQX, N29, NTAR, E-commerce, 3D printing

VANCOUVER, British Columbia, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nextech AR Solutions Corp. (OTCQX:NEXCF) (CSE:NTAR) (FSE:N29), a Metaverse Company and leading provider of augmented reality experience technologies and 3D model services, announced a patent update covering its artificial intelligence technology 3D model creation.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nextech AR Solutions Corp. (OTCQX:NEXCF) (CSE:NTAR) (FSE:N29), a Metaverse Company and leading provider of augmented reality experience technologies and 3D model services, announced a patent update covering its artificial intelligence technology 3D model creation.
  • At that time, the company began implementing this breakthrough part-based 3D model creation technology and by using what it calls “through composition of deformable parts” has expanded its library to more than 100,000 3D model parts.
  • These parts are used to create a 3D model as most 3D models are composed of several individual parts.
  • Investor Relations is handled by Lindsay Betts, who can be reached at 866-274-8493 Ext 7201 or by email at [email protected] .

The Top HR Outsourcing Companies In January, According To DesignRush

Retrieved on: 
Tuesday, January 3, 2023
Organization, Saudi Research and Marketing Group, HR, Growth, Marketing, Research

MIAMI, Jan. 3, 2023 /PRNewswire-PRWeb/ -- According to Research and Markets, the global human resource outsourcing market is predicted to increase from $32.8 billion in 2020 to $53.2 billion in 2027. This growth can be attributed to factors such as the increasing complexity of HR tasks and the need for cost-effective solutions.

Key Points: 
  • The global HR outsourcing market is set to reach $53.2 billion by 2027.
  • DesignRush revealed the top HR outsourcing companies that help businesses access specialized HR expertise and save costs.
  • DesignRush , a B2B marketplace connecting businesses with agencies, listed the best HR outsourcing companies that help organizations streamline their HR processes and improve efficiency.
  • The top HR outsourcing companies in January are:
    Brands can explore the top HR outsourcing companies by location, size, average hourly rate and portfolio on DesignRush.

XtalPi and EDDC collaborate in AI-empowered drug discovery program for Non-Small Cell Lung Cancer

Retrieved on: 
Tuesday, December 20, 2022
Longevity, Patient, Drug discovery, Saudi Research and Marketing Group, Large-cell lung carcinoma, Health, Drug development, Partnership, AI, Market, Physics, ID4, Lung cancer, Agency, Automation, Drug design, Pan-Asia, Therapy, Experimental drug, Artificial intelligence, NSCLC, Incidence, Cancer, EDDC, Machine learning, Pharmaceutical industry, Fine chemical, Medical device, Science, Research

SHENZHEN, China and SINGAPORE, Dec. 19, 2022 /PRNewswire/ -- XtalPi, a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, today announced a strategic collaboration with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development hosted by the Agency for Science, Technology and Research of Singapore (A*STAR), to discover novel treatment candidates for non-small cell lung cancer (NSCLC). 

Key Points: 
  • Lung cancer is the second most common cancer and the leading cause of cancer death worldwide.
  • NSCLC accounts for over 80% of all lung cancer cases and its incidence continues to increase globally.
  • EDDC will offer valuable insight and data on the novel NSCLC target, further accelerating the drug discovery process and propelling the program towards development.
  • Dr. Shuhao Wen, co-founder and chairman of XtalPi, comments: "We are delighted to establish this strategic collaboration with EDDC.

Fintech Innovation and the Digital Path of Banking in the Future

Retrieved on: 
Thursday, December 8, 2022
WorldPay, Honey, Crypto, Mobile backend as a service, Acquisition, Software, Bank of America Merchant Services, Marketing, Sale, Climate change, Merchant services, PayPal, Hotel manager, Face, Growth, Mining, COVID-19, Policy, IR, Holiday, Commerce, Martech, Saudi Research and Marketing Group, Health, Water, Worldpay, AT&T, Toyota Financial Services, AT, Alexander, News, Bank, Sport, Cannabis, Clean technology, Social media, AI, Platform as a service, Black, Afterpay, Publishing, CXS, Ecosystem, Wells Fargo, Capital One, Risk, Online shopping, Management, Square, Research, Financial technology, Payoneer

According to Research and Markets , "The global fintech market size reached US$ 131.14 Billion in 2021.

Key Points: 
  • According to Research and Markets , "The global fintech market size reached US$ 131.14 Billion in 2021.
  • CXS solutions incorporate PaaS, BaaS, Data, AI/ML, MarTech and other features to create flexible, rich, personalized payment and banking experiences for end users.
  • "AppTech's mission is to deliver a better way for businesses to provide their customers with customizable commerce experiences.
  • Disclosure: this news article featuring APCX is a paid for news release on Investorideas.com, part of the monthly content program.

InvestmentPitch Media Video Discusses Nextech AR Solutions’ Planned IPO Spinoff of its 3D Design Studio, Targeting the Multi-Billion Dollar Computer Aided Design Market

Retrieved on: 
Thursday, December 15, 2022
Metaverse, NTAR, AR, Saudi Research and Marketing Group, Research, E-commerce, Marketing, N29, Suggestion, 3D, News, FSE, CAD, IPO, CSE, OTCQB, Iveco Bus, Risk, Software as a service, Television

The video is available for viewing on “ InvestmentPitch ” and on “ YouTube ”.

Key Points: 
  • The video is available for viewing on “ InvestmentPitch ” and on “ YouTube ”.
  • If these links are not enabled, please visit www.InvestmentPitch.com and enter “Nextech” in the search box.
  • This follows the highly successful spin out of ARway Corporation in October, which traded as high as $2.95.
  • Nextech AR Solutions has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format.

American Pharmaceutical Review and Pharmaceutical Outsourcing Release Documentary on Cell and Gene Therapies

Retrieved on: 
Friday, December 16, 2022
Editorial, Gene, API, ATMP, Cell, FDA, Saudi Research and Marketing Group, Medication, SAN, Advanced Therapy Medicinal Product, Hope, Information technology, USD, Fine chemical, Pharmaceutical industry, Research

SAN FRANCISCO, Dec.16, 2022 /PRNewswire-PRWeb/ -- American Pharmaceutical Review, the leading review of business and technology for the pharmaceutical industry throughout North America and Pharmaceutical Outsourcing magazine a journal dedicated to pharmaceutical and biopharmaceutical contract services that provides the most complete coverage of trends and issues in the industry have released their documentary on "Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals". The goal of the documentary is to examine how cell and gene therapies, which fall into the broader category of drugs known as Advanced Therapy Medicinal Products (ATMPs) have emerged as an incredibly promising class of treatments that have shown the ability to treat and even cure many individuals with diseases for which there was little to no hope.

Key Points: 
  • SAN FRANCISCO, Dec.16, 2022 /PRNewswire-PRWeb/ -- American Pharmaceutical Review, the leading review of business and technology for the pharmaceutical industry throughout North America and Pharmaceutical Outsourcing magazine a journal dedicated to pharmaceutical and biopharmaceutical contract services that provides the most complete coverage of trends and issues in the industry have released their documentary on " Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals ".
  • says Mike Auerbach, Editor in Chief, American Pharmaceutical Review and Pharmaceutical Outsourcing.
  • For more information on this documentary on Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals please visit: https://www.americanpharmaceuticalreview.com/Cell-and-Gene-Therapy/ .
  • American Pharmaceutical Review is the leading journal for business and technology in the pharmaceutical industry.